UNSPSC 51385616: Aspirin magnesium

This classification denotes a cyclooxygenase inhibitor with the molecular formula 2C9H7O4.Mg, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4995924SMK, chemically known as magnesium 2-(acetyloxy)benzoate, but more generally known as aspirin magnesium, which bears US NIH Compound Identifier 8591. European Medicines Agency schedules aspirin magnesium or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20435. Most nations, for tariff purposes, schedule aspirin magnesium under HS 29182200.

SMILES: CC(=O)OC1CCCCC1C(=O)[O-].CC(=O)OC1CCCCC1C(=O)[O-].[MG+2].

UNSPSC 51385616 Aspirin magnesium is a Commodity code that does not align with the recent state and local procurement activity posted under it. Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, solicits naloxone and drug deactivation systems for community health initiatives — a pharmaceutical and harm-reduction product line unrelated to aspirin magnesium formulations. The mismatch between the code's nominal scope and the actual work being bought suggests either a data-entry error in the opportunity's UNSPSC classification or a fundamental misalignment in how the county's e-procurement system tagged the solicitation.

No recent opportunities directly addressing aspirin magnesium procurement appear in the available state and local contract record. If firms pursue pharmaceutical and over-the-counter medication supply contracts with state and local health departments, school districts, or county community health operations, they should verify the UNSPSC coding on posted opportunities and conduct their own searches for naloxone, pain-relief medications, or broader pharmaceutical-supply codes rather than rely on the 51385616 classification shown here.